Business Context and Reporting Period
This Form 6-K/A filing by GlaxoSmithKline plc (GSK) covers the period ending January 2015, with the report dated January 22, 2015. The document serves as a notification of transactions involving Directors and Persons Discharging Managerial Responsibility (PDMR) in accordance with DTR 3.1.4R(1)(a) and (c).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document is limited to reporting specific share transaction details rather than comprehensive financial performance.
Key transaction data provided:
- Transaction Date: January 15, 2015
- Transaction Type: Increase in American Depositary Shares (ADSs) via dividend re-investment.
- Dividend Payment Date: January 8, 2015
- Price per ADS: $42.60
Material Changes
The filing reports increases in share interests for the following individuals due to the re-investment of dividends:
- Dr M M Slaoui: 1,626.645 ADSs
- Mrs D P Connelly: 995.662 ADSs
- Mr W C Louv: 322.550 ADSs
- Mr N Hirons: 175.590 ADSs
- Mr D E Troy: 1,008.073 ADSs
- Dr K Slaoui (Connected Person): 52.717 ADSs
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is strictly a regulatory disclosure of insider trading activity.
Investor Verification Points
- Verify the total number of ADSs held by each listed Director and PDMR following these transactions.
- Confirm the dividend amount per share that resulted in the specific ADS increases listed.
- Check subsequent filings for any further changes in director interests or related party transactions.